These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 1948034)
1. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Shimada S; Kitayama S; Lin CL; Patel A; Nanthakumar E; Gregor P; Kuhar M; Uhl G Science; 1991 Oct; 254(5031):576-8. PubMed ID: 1948034 [TBL] [Abstract][Full Text] [Related]
2. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Kilty JE; Lorang D; Amara SG Science; 1991 Oct; 254(5031):578-9. PubMed ID: 1948035 [TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198 [TBL] [Abstract][Full Text] [Related]
4. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. Giros B; el Mestikawy S; Bertrand L; Caron MG FEBS Lett; 1991 Dec; 295(1-3):149-54. PubMed ID: 1765147 [TBL] [Abstract][Full Text] [Related]
5. Cloning of the cocaine-sensitive bovine dopamine transporter. Usdin TB; Mezey E; Chen C; Brownstein MJ; Hoffman BJ Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11168-71. PubMed ID: 1722321 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271 [TBL] [Abstract][Full Text] [Related]
7. Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-ethylmaleimide-induced reduction of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding. Reith ME; Xu C; Coffey LL Biochem Pharmacol; 1996 Nov; 52(9):1435-46. PubMed ID: 8937455 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a recombinant human dopamine transporter in multiple cell lines. Eshleman AJ; Neve RL; Janowsky A; Neve KA J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409 [TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains. Lin Z; Wang W; Uhl GR Mol Pharmacol; 2000 Dec; 58(6):1581-92. PubMed ID: 11093799 [TBL] [Abstract][Full Text] [Related]
10. The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines. Pƶrzgen P; Park SK; Hirsh J; Sonders MS; Amara SG Mol Pharmacol; 2001 Jan; 59(1):83-95. PubMed ID: 11125028 [TBL] [Abstract][Full Text] [Related]
11. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55. Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327 [TBL] [Abstract][Full Text] [Related]
12. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter. Jayanthi LD; Apparsundaram S; Malone MD; Ward E; Miller DM; Eppler M; Blakely RD Mol Pharmacol; 1998 Oct; 54(4):601-9. PubMed ID: 9765501 [TBL] [Abstract][Full Text] [Related]
13. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis. Chen N; Vaughan RA; Reith ME J Neurochem; 2001 May; 77(4):1116-27. PubMed ID: 11359877 [TBL] [Abstract][Full Text] [Related]
14. Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter. Ferrer JV; Javitch JA Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9238-43. PubMed ID: 9689064 [TBL] [Abstract][Full Text] [Related]
15. Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter. Lee SH; Chang MY; Lee KH; Park BS; Lee YS; Chin HR; Lee YS Mol Pharmacol; 2000 May; 57(5):883-9. PubMed ID: 10779370 [TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics. Sato T; Kitayama S; Mitsuhata C; Ikeda T; Morita K; Dohi T Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):214-20. PubMed ID: 10685879 [TBL] [Abstract][Full Text] [Related]
17. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding. Wall SC; Innis RB; Rudnick G Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827 [TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression. Lin Z; Itokawa M; Uhl GR FASEB J; 2000 Apr; 14(5):715-28. PubMed ID: 10744628 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884 [TBL] [Abstract][Full Text] [Related]
20. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions. Itokawa M; Lin Z; Cai NS; Wu C; Kitayama S; Wang JB; Uhl GR Mol Pharmacol; 2000 Jun; 57(6):1093-103. PubMed ID: 10825379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]